The link between psoriasis, obesity, and fatty liver highlights how systemic inflammation can persist and fuel other health complications, even when skin symptoms improve.

A study published in the assessed the association of liver fibrosis with cumulative methotrexate dose and other liver fibrosis risk factors in patients with a history of moderate-to-severe psoriasis.

Philadelphia, May 20, 2025 – New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader ...

While patients with psoriasis-- a chronic skin condition -- respond well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and ...

Even when medication clears skin symptoms, people with psoriasis can still have inflammation throughout their bodies that increases the risk of obesity, heart disease, and liver issues. A new ...

Researchers from King’s College London evaluated 25 different measurements of body fat and found that those related to the ...

Psoriasis, a chronic inflammatory skin condition characterized by dry and scaly skin lesions, affects about 7.5 million people in the United States. Psoriasis results from abnormal proliferation ...

Research from 2022 showed that glutathione levels were lower in people with psoriasis. This research suggests that the use of dimethyl fumarate, a medication typically for treating multiple ...

Scientists believe the hormone hepcidin, when produced in the skin, may be the root cause of psoriasis -- a chronic and sometimes debilitating skin disease that affects 2-3% of the global population.

This study reveals hepcidin's significant role in psoriasis, linking iron retention to inflammation and keratinocyte growth, suggesting new therapeutic targets.

Approval is based on data from phase 2b and 3 studies. In the pivotal phase 3 ARRECTOR study recently published in JAMA Dermatology, 432 patients with scalp and body psoriasis aged 12 years and ...

New Delhi, May 20 : While patients with psoriasis -- a chronic skin condition -- respond well to treatment with biologics, inflammation can linger, leading to broader health implications such as ...